NATALIE YAKLIN: Open Payments
NPI 1699192328 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 43 payments from 11 companies in 2025. Trend: 2023 $1,507 · 2024 $1,124 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $267 |
| ARGENX US, INC. | 9 | $217 |
| PFIZER INC. | 5 | $94 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| GENZYME CORPORATION | 1 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Biogen, Inc. | 2 | $41 |
| Eisai Inc. | 1 | $30 |
| Philips North America LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
Products named: VYVGART HYTRULO, QULIPTA, NURTEC ODT, Sunosi, UBRELVY, FABRAZYME, PONVORY, VUMERITY.
Industry payments across TX — which companies pay providers there.
